Clinical trials
Malaria, Falciparum trials in Tanzania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 6 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Terminated | 3 |
| Unknown status | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| University of Oxford | 5 |
| Sanaria Inc. | 4 |
| Muhimbili University of Health and Allied Sciences | 3 |
| Swiss Tropical & Public Health Institute | 3 |
| Ifakara Health Institute | 2 |
| Medicines for Malaria Venture | 2 |
| Anders Björkman | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Duke University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria, Falciparum | 42 |
| Malaria | 25 |
| Anemia | 3 |
| Acquired Immunodeficiency Syndrome | 1 |
| Asymptomatic Infections | 1 |
| Coccidiosis | 1 |
| Communicable Diseases | 1 |
| Disease | 1 |
| HIV Infections | 1 |
| Lymphoma, Follicular | 1 |
Trials
Showing 51 to 42 of 42. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.